Michael D Roth

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Statistical mechanics in chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Translating a Preclinical Hydrogel Platform into a Human Therapeutic for Delivering Targeted Low-Dose Anti-CTLA-4.

|Nov 26, 2025
Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Dinesh Khanna, Cathie Spino, Donald P Tashkin

|Apr 26, 2020
Peri-tumor administration of controlled release anti-CTLA-4 synergizes with systemic anti-PD-1 to induce systemic antitumor immunity while sparing autoimmune toxicity.

Airi Harui, Sandra M McLachlan, Basil Rapoport

|Jul 13, 2019
Pulmonary effects of inhaled cannabis smoke.

Donald P Tashkin, Michael D Roth

|Apr 23, 2015
Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model.

Michael D Roth, Airi Harui

Pageof 1

Frequent Collaborators

1 joint publications

Donald P Tashkin

1 joint publications

Dinesh Khanna

1 joint publications

Grace Hyun J Kim

1 joint publications

Vivek Nagaraja